QA: Zevra Therapeutics INC in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001434647_2017_Zevra_Therapeutics_INC.pdf

Logs

warning Missing logo subcommand.report {}
warning Expenses in unusual place in relation to revenue input.sec.calculation_linkbase.edgar_model_mapping {'expenses_node': 'OperatingExpenses', 'revenue_node': 'SalesRevenueNet', 'net_inc_node': 'NetIncomeLoss'}

Graph

Absolute values for 0001434647, Zevra Therapeutics INC

  xvar xval
0 AssetsCurrent 74,357,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,970,000
3 remainder_Assets 8,560,000
4 LiabilitiesCurrent 6,642,000
5 LiabilitiesNoncurrent 1,153,000
6 remainder_Liabilities 95,788,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 14,000,000
9 ResearchAndDevelopmentExpense 20,472,000
10 remainder_Expenses 6,005,000
11 remainder_Revenues 0
12 remainder_NetIncome 20,951,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 84,887,000
1 Liabilities 103,583,000
2 Expenses 40,477,000
3 Revenues 0
4 StockholdersEquity -18,696,000
5 NetIncome -19,526,000
6 ComprehensiveNetIncome -19,526,000
7 BaseVar 124,949,000
8 EconomicCapitalRatiobeforeLimitedLiability -0.640
9 EconomicCapitalRatio 1.37

Edgar->Model Mapping

Feature Distribution

Change over Time